Life Sciences Executives Flash Report
Projections & Priorities for 2024/25
What do executives from the Life Sciences industry expect for 2024/25, where do they see challenges and what are the main trend impacts?
Once again, we surveyed C-level executives from the pharma, BioTech and MedTech sectors to gain insights into their projections and priorities and to draw a current picture of the industry.
One of our key findings: Executives see a positive top line growth trend for 2024 and are even more optimistic for 2025, despite ongoing challenges in the market.
Read the full report to find out what is expected for the bottom line, how ESG is rated and what might be upcoming challenges. We have also put together five things to consider for the upcoming years.
.
Click here for the Flash Report!
Your Contact
Dr. Philipp Temmel